Roger Jeffs serves as Executive at UNITED THERAPEUTICS CORP, where they oversee executive responsibilities. Since joining the company, Roger Jeffs has executed 706 insider transactions totaling $190.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 16, 2026 involved receiving (via award) 173,016 shares valued at $0.
Roger Jeffs currently holds 173,016 shares of UNITED THERAPEUTICS CORP (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roger Jeffs has been a net seller of UTHR stock. They have purchased $2.6M and sold $187.6M worth of shares.
Roger Jeffs's most recent insider trade was on Jan 16, 2026, when they sold 173,016 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 13, 2025 | LQDA | $474.3K | Sale | 20,261 | $23.41 | Discretionary |
| Oct 10, 2025 | LQDA | $0 | Option Exercise | 13,834 | $N/A | Discretionary |
| Sep 2, 2025 | AXSM | $1.7M | Sale | 13,464 | $123.68 | Discretionary |
| Aug 29, 2025 | AXSM | $2.4M | Sale | 20,000 | $121.27 | Discretionary |
| Aug 28, 2025 | AXSM | $2.4M | Sale | 20,000 | $121.60 | Discretionary |
| Aug 27, 2025 | AXSM | $2.4M | Sale | 20,000 | $122.30 | Discretionary |
| Aug 26, 2025 | AXSM | $2.4M | Sale | 20,000 | $120.03 | Discretionary |
| Aug 22, 2025 | AXSM | $2.0M | Sale | 16,694 | $120.08 | Discretionary |
| Jul 14, 2025 | LQDA | $289.2K | Sale | 20,252 | $14.28 | Discretionary |
| Jul 14, 2025 | LQDA | $289.2K | Sale | 20,252 | $14.28 | Discretionary |
| Jul 11, 2025 | LQDA | $0 | Option Exercise | 13,833 | $N/A | Discretionary |
| Jul 11, 2025 | LQDA | $0 | Option Exercise | 13,833 | $N/A | Discretionary |
| Jul 12, 2024 | LQDA | $100.9K | Sale | 8,053 | $12.53 | Planned |
| Apr 12, 2024 | LQDA | $121.9K | Sale | 8,360 | $14.58 | Planned |
| Mar 18, 2024 | LQDA | $452.2K | Sale | 28,583 | $15.82 | Planned |
| Mar 15, 2024 | AXSM | $70.2K | Option Exercise | 2,347 | $29.91 | Planned |
| Mar 15, 2024 | AXSM | $168.1K | Sale | 2,347 | $71.61 | Planned |
| Mar 14, 2024 | AXSM | $433.4K | Option Exercise | 16,976 | $25.53 | Planned |
| Mar 14, 2024 | AXSM | $286.4K | Option Exercise | 13,000 | $22.03 | Planned |
| Mar 14, 2024 | AXSM | $1.2M | Sale | 16,976 | $69.70 | Planned |
| Mar 14, 2024 | AXSM | $906.1K | Sale | 13,000 | $69.70 | Planned |
| Jan 11, 2024 | LQDA | $0 | Award | 221,338 | $N/A | Discretionary |
| Dec 14, 2023 | LQDA | $1.0M | Purchase | 139,665 | $7.16 | Discretionary |
| Jan 11, 2023 | LQDA | $0 | Award | 289,500 | $N/A | Discretionary |
| Jan 3, 2023 | LQDA | $0 | Option Exercise | 15,807 | $N/A | Discretionary |
| Oct 3, 2022 | LQDA | $0 | Option Exercise | 47,423 | $N/A | Discretionary |
| Sep 6, 2022 | LQDA | $244.1K | Purchase | 43,820 | $5.57 | Discretionary |
| Aug 31, 2022 | LQDA | $4.9K | Award | 993 | $4.90 | Discretionary |